168 related articles for article (PubMed ID: 36734963)
1. Visual Field Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Chromatic Perimetry.
McAnany JJ; Park JC; Lim JI
Invest Ophthalmol Vis Sci; 2023 Feb; 64(2):8. PubMed ID: 36734963
[TBL] [Abstract][Full Text] [Related]
2. SHORT-WAVELENGTH AUTOMATED PERIMETRY IN DIABETIC PATIENTS WITHOUT RETINOPATHY.
Peprníková S; Skorkovská K; Květon P
Cesk Slov Oftalmol; 2021; 77(5):248-252. PubMed ID: 34666494
[TBL] [Abstract][Full Text] [Related]
3. Multifocal Pupillography Identifies Changes in Visual Sensitivity According to Severity of Diabetic Retinopathy in Type 2 Diabetes.
Sabeti F; Nolan CJ; James AC; Jenkins A; Maddess T
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4504-13. PubMed ID: 26200488
[TBL] [Abstract][Full Text] [Related]
4. Structural and Functional Abnormalities in Early-stage Diabetic Retinopathy.
Park JC; Chen YF; Liu M; Liu K; McAnany JJ
Curr Eye Res; 2020 Aug; 45(8):975-985. PubMed ID: 31847599
[TBL] [Abstract][Full Text] [Related]
5. Short wavelength automated perimetry can detect visual field changes in diabetic patients without retinopathy.
Zico OA; El-Shazly AA; Abdel-Hamid Ahmed EE
Indian J Ophthalmol; 2014 Apr; 62(4):383-7. PubMed ID: 24817740
[TBL] [Abstract][Full Text] [Related]
6. Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy.
Jackson GR; Scott IU; Quillen DA; Walter LE; Gardner TW
Br J Ophthalmol; 2012 May; 96(5):699-703. PubMed ID: 22174096
[TBL] [Abstract][Full Text] [Related]
7. Short-wavelength sensitive visual field loss in patients with clinically significant diabetic macular oedema.
Hudson C; Flanagan JG; Turner GS; Chen HC; Young LB; McLeod D
Diabetologia; 1998 Aug; 41(8):918-28. PubMed ID: 9726594
[TBL] [Abstract][Full Text] [Related]
8. Early visual field changes in patients with type 1 diabetes mellitus.
Ozates S; Simsek M; Elgin U; Keskin M; Aycan Z
Eur J Ophthalmol; 2020 Nov; 30(6):1467-1472. PubMed ID: 31466476
[TBL] [Abstract][Full Text] [Related]
9. Visual field indices and patterns of visual field deficits in mesopic and dark-adapted two-colour fundus-controlled perimetry in macular diseases.
Pfau M; Lindner M; Steinberg JS; Thiele S; Brinkmann CK; Fleckenstein M; Holz FG; Schmitz-Valckenberg S
Br J Ophthalmol; 2018 Aug; 102(8):1054-1059. PubMed ID: 29146759
[TBL] [Abstract][Full Text] [Related]
10. Pupillometer-based objective chromatic perimetry in normal eyes and patients with retinal photoreceptor dystrophies.
Skaat A; Sher I; Kolker A; Elyasiv S; Rosenfeld E; Mhajna M; Melamed S; Belkin M; Rotenstreich Y
Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2761-70. PubMed ID: 23482470
[TBL] [Abstract][Full Text] [Related]
11. THE ROLE OF FREQUENCY DOUBLING TECHNOLOGY PERIMETRY IN EARLY DETECTION OF DIABETIC RETINOPATHY.
Bradvica M; Biuk D; Štenc Bradvica I; Vinković M; Cerovski B; Barać I
Acta Clin Croat; 2020 Mar; 59(1):10-18. PubMed ID: 32724270
[TBL] [Abstract][Full Text] [Related]
12. Ganglion cell losses underlying visual field defects from experimental glaucoma.
Harwerth RS; Carter-Dawson L; Shen F; Smith EL; Crawford ML
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2242-50. PubMed ID: 10476789
[TBL] [Abstract][Full Text] [Related]
13. The application of chromatic dark-adapted kinetic perimetry to retinal diseases.
Rotenstreich Y; Fishman GA; Lindeman M; Alexander KR
Ophthalmology; 2004 Jun; 111(6):1222-7. PubMed ID: 15177975
[TBL] [Abstract][Full Text] [Related]
14. Multimodal characterization of proliferative diabetic retinopathy reveals alterations in outer retinal function and structure.
Boynton GE; Stem MS; Kwark L; Jackson GR; Farsiu S; Gardner TW
Ophthalmology; 2015 May; 122(5):957-67. PubMed ID: 25601533
[TBL] [Abstract][Full Text] [Related]
15. Retinal Sensitivity in Patients with Type I Diabetes without Retinopathy or with Minor Retinal Changes.
Pinilla I; Sanchez-Cano A; Ferreras A; Acha J; Pérez-García D; Ibañez-Alperte J; Abecia E
Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):613-617. PubMed ID: 27657998
[No Abstract] [Full Text] [Related]
16. Blue cone monochromacy: visual function and efficacy outcome measures for clinical trials.
Luo X; Cideciyan AV; Iannaccone A; Roman AJ; Ditta LC; Jennings BJ; Yatsenko SA; Sheplock R; Sumaroka A; Swider M; Schwartz SB; Wissinger B; Kohl S; Jacobson SG
PLoS One; 2015; 10(4):e0125700. PubMed ID: 25909963
[TBL] [Abstract][Full Text] [Related]
17. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial.
Scott IU; Jackson GR; Quillen DA; Klein R; Liao J; Gardner TW
JAMA Ophthalmol; 2014 Sep; 132(9):1137-42. PubMed ID: 24969516
[TBL] [Abstract][Full Text] [Related]
18. Quantifying rod photoreceptor-mediated vision in retinal degenerations: dark-adapted thresholds as outcome measures.
Roman AJ; Schwartz SB; Aleman TS; Cideciyan AV; Chico JD; Windsor EA; Gardner LM; Ying GS; Smilko EE; Maguire MG; Jacobson SG
Exp Eye Res; 2005 Feb; 80(2):259-72. PubMed ID: 15670804
[TBL] [Abstract][Full Text] [Related]
19. Scanning laser entoptic perimetry for the detection of visual defects associated with diabetic retinopathy.
El-Bradey M; Plummer DJ; Uwe-Bartsch D; Freeman WR
Br J Ophthalmol; 2006 Jan; 90(1):17-9. PubMed ID: 16361659
[TBL] [Abstract][Full Text] [Related]
20. Mesopic and Scotopic Light Sensitivity and Its Microstructural Correlates in Pseudoxanthoma Elasticum.
Hess K; Gliem M; Charbel Issa P; Birtel J; Müller PL; von der Emde L; Herrmann P; Holz FG; Pfau M
JAMA Ophthalmol; 2020 Dec; 138(12):1272-1279. PubMed ID: 33090206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
